Medikine is a biopharmaceutical discovery company that develops cytokine and growth factor receptor agonists. Its technology platform helps to identify agonists of clinically relevant heterodimeric cytokine receptors. The company's research programs are focused on the use of IL-2Rβ/γ agonist peptide in immuno-oncology applications, cell therapy, and neo-antigen vaccines.